Stocks / Pharmaceuticals
QUREPharmaceuticals
uniQure N.V.
$44.521d +4.8%5d -3.0%settled close · 2026-09-17
Mkt cap $949M (3/25)β -1.2352w $17.09–51Shares 62.5MInd. Pharmaceutical PreparationsNasdaq since 2014Emp. 221HQ Amsterdamuniqure.com
Who’s talkingIdea Scout · free
Who’s talking about QURE
No tracked investor commentary on QURE yet — the corpus grows weekly.
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
Earnings
Next report: 9 Nov 2026 before the open
Confirmed date · consensus EPS -0.96. Reactions below are the next settled session over the prior close.
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where QURE’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 7 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-02 | ||||||
| 2026-08-10 | ||||||
| 2026-08-07 | ||||||
| 2026-07-28 | ||||||
| 2026-06-25 | ||||||
| 2026-06-18 | ||||||
| 2026-06-17 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
QURE is in this morning’s Brief.
Get The Brief — $20/mo →